SCHEMBL7344308

SCHEMBL7344308

Cc1ccc(S(=O)(=O)OC[C@H]2CCCN2OC=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
PKM P14618 2/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
FFAR1 O14842 1/20 0.40
CASP3 P42574 1/20 0.40
CASP7 P55210 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTR6 P50406 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
DRD2 P14416 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428109 0.81 HTR6 (0.50) CYP2D6HTR6DRD2DRD1DRD4
SCHEMBL12428110 0.81 HTR6 (0.50) CYP2D6HTR6DRD2DRD1DRD4
SCHEMBL28159934 0.79 ALDH1A1 (0.45) ALDH1A1PKMPOLBHTTCYP2D6
SCHEMBL8206528 0.78 CASP3 (0.55) CASP3CASP7GAA
SCHEMBL8206525 0.78 CASP3 (0.55) CASP3CASP7GAA
SCHEMBL5337048 0.78 CASP3 (0.55) CASP3CASP7GAA
SCHEMBL17846419 0.77 CYP2D6 (0.42) ALDH1A1PKMPOLBHTTCYP2D6
SCHEMBL9676145 0.77 HTR6 (0.46) CYP2D6CYP1A2HTR6DRD2DRD1
SCHEMBL2302585 0.76 FFAR1 (0.45) ALDH1A1POLBCYP2D6CYP1A2FFAR1
SCHEMBL16032028 0.76 ALDH1A1 (0.44) ALDH1A1POLBCYP2D6CYP1A2FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583146-A Heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-10 US disclosed
EP-0623595-A1 Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1994-11-09 EP disclosed